ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
USPTO (United States) · Serial 85525635
- Status
- abandoned
- Status updated
- 1 July 2013
- Filing date
- 26 January 2012
- Registration date
- -
- Nice classification
- 42
- Owner
- Bristol-Myers Squibb Company
- Owner country
- US
- Raw status code
- 602
As filed by US
Authoritative source
The official US trademark record is at USPTO TSDR (serial 85525635) ↗. Where our data differs from the USPTO record, theirs is correct.
See methodology for refresh cadence + status normalisation. See sources for licensing.